GlassScriptPhysician profile
Sarah Katz
NPI 1851517726
$1,086.36
in general payments reported to CMS, 2019-2025
17 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $49.52 · 2023: $220 · 2024: $328 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $342.54 | 2021-2025 | |
| Janssen Biotech, INC. | $167.93 | 2024-2025 | Tecvayli, Darzalex, Talvey |
| Gilead Sciences, INC. | $126.76 | 2022-2025 | Trodelvy |
| Merck Sharp & Dohme LLC | $63.29 | 2024-2025 | Keytruda, Keytruda Qlex |
| E.R. Squibb & Sons, L.L.C. | $60.16 | 2021-2024 | Krazati |
| Lilly USA, LLC | $51.89 | 2021-2023 | Jaypirca, Retevmo |
| Celgene Corporation | $39.95 | 2023-2024 | Reblozyl |
| Puma Biotechnology, INC. | $39.84 | 2023-2024 | |
| Array Biopharma INC | $35.70 | 2021 | |
| Pharmaessentia USA Corporation | $33.64 | 2024-2025 | Besremi |
| Pfizer INC. | $21.00 | 2021 | |
| Cti Biopharma Corp. | $20.80 | 2023 | Vonjo |
| Agios Pharmaceuticals, INC. | $18.55 | 2025 | Pyrukynd |
| Tersera Therapeutics LLC | $18.01 | 2025 | Zoladex |
| Seagen INC. | $17.60 | 2023 | Padcev |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Taiho Oncology, INC. | $14.38 | 2025 | |
| Genentech USA, INC. | $14.32 | 2023 | Polivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.